Marc A. Ruel
Experienced in Brachial Plexopathy

Marc A. Ruel

3402-40 Ruskin St, K1Y 4W7, 
Ottawa, ON, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Brachial Plexopathy
3402-40 Ruskin St, K1Y 4W7, 
Ottawa, ON, CA 
OverviewLocationsClinical Research

Overview

Marc Ruel practices in Ottawa, Canada. Mr. Ruel is rated as an Experienced expert by MediFind in the treatment of Brachial Plexopathy. His top areas of expertise are Coronary Heart Disease, Mitral Valve Regurgitation, Aortic Valve Stenosis, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

His clinical research consists of co-authoring 367 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Brachial Plexopathy.

Gender
Male

Locations

3402-40 Ruskin St, K1Y 4W7, Ottawa, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
Enrollment Status: Recruiting
Publish Date: February 07, 2025
Intervention Type: Drug
Study Drugs: Antiplatelet-only strategy, Anticoagulant+Background antiplatelet therapy
Study Phase: Phase 3
Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: the ROMA Trial
Randomized Comparison of the Clinical Outcome of Single Versus Multiple Arterial Grafts: the ROMA Trial
Enrollment Status: Active_not_recruiting
Publish Date: May 23, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention
Randomized Trial Of Hybrid Coronary Revascularization Versus Percutaneous Coronary Intervention
Enrollment Status: Completed
Publish Date: May 23, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT)
Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT)
Enrollment Status: Completed
Publish Date: December 24, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug
Study Phase: Phase 3
On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study
Enrollment Status: Active_not_recruiting
Publish Date: October 08, 2024
Intervention Type: Device
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
Evaluating the Benefit of Concurrent Tricuspid Valve Repair During Mitral Surgery
Enrollment Status: Completed
Publish Date: June 18, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban
A Prospective, Randomized, Active (Warfarin) Controlled, Parallel-arm Clinical Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely and Effectively on Apixaban
Enrollment Status: Terminated
Publish Date: March 20, 2024
Intervention Type: Drug, Device
Study Drugs: Apixaban, Warfarin
Study Phase: Phase 3
Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET Trial): Does Ticagrelor Improve Graft Patency After Coronary Bypass?
Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET Trial): Does Ticagrelor Improve Graft Patency After Coronary Bypass?
Enrollment Status: Completed
Publish Date: September 14, 2022
Intervention Type: Drug
Study Drugs: Aspirin, Ticagrelor
Study Phase: Phase 4
View 8 Less Clinical Trials

367 Total Publications

Broadening the applicability of coronary surgery from minimally invasive approaches to the modern treatment of ventricular septal rupture.
Broadening the applicability of coronary surgery from minimally invasive approaches to the modern treatment of ventricular septal rupture.
Journal: Current opinion in cardiology
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ruel's expertise for a condition
ConditionClose
View All 11 Advanced Conditions
View All 30 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile